PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates by Andrew Khouri | Feb 15, 2024
Cytotoxic effects of LRRK2 inhibitors in combined treatment with chemotherapeutic agents on a large panel of cancer cell lines by Reaction Biology | Jul 6, 2023
Real-time quantitative PCR based analysis of transcriptional effects of CDK8/Cyclin C inhibitors by Reaction Biology | Jul 6, 2023
Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery. Journal of Biomolecular Screening, 2014 by Reaction Biology | Jul 6, 2023